CTMS

The CRI’s successful development of a Clinical Trials Management System (CTMS) for the University of Chicago continues on pace this autumn as we prepare for the launch of the system. After a year of iterative work to develop and test key components, the project is now in the final user acceptance testing phase and is set for deployment in mid-November 2018. Once the CTMS is in production, all new clinical trials at the University will be initiated within it.

With our system, which includes a fully functional front end for budgeting and reporting in addition to managing clinical data, all information for University of Chicago clinical trials will be easily accessible in one place. The CRI has extended our relationship with Bad Rabbit Consulting and will continue to work closely with their research administration experts as we manage and further develop the CTMS after it is in production. We look forward to the successful deployment of this enterprise system that will unify, standardize, and modernize clinical research efforts across the BSD.

The CRI’s development of an enterprise Clinical Trials Management System (CTMS) to unify, standardize, and modernize clinical research efforts across the BSD continues on track this spring. Since the source code development phase began in August 2017, our team has been working to develop the key components of the system, and are currently on schedule with this development process. The team’s Continuous Integration development method has each iteration of the software in the hands of testers and stakeholders early and often and allows early detection of any potential code integration issues. 

The CRI-led Clinical Trials Management System project, which began in October of last year, will enter its source code development phase on Wednesday, August 9. This phase will be officially launched at a meeting attended by key stakeholders across the BSD and UCM. Updates throughout the development phase will be available on the CRI website. Learn more about this project and meet the team here.